DIN 02293269 — CAMPRAL 333 MG
CAMPRAL is a tablet (delayed-release) of Acamprosate marketed by MYLAN PHARMACEUTICALS ULC. The full Acamprosate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02293269
- Brand name
- CAMPRAL
- Active ingredient
- Acamprosate
- Strength
- 333 MG
- Dosage form
- TABLET (DELAYED-RELEASE)
- Route
- ORAL
- Manufacturer
- MYLAN PHARMACEUTICALS ULC
- Health Canada status
- MARKETED
- Drug class
- GABA/glutamate neurotransmission modulator (alcohol abstinence maintenance agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.